No Detail Found!

Effectuation of loading a natural acetyl carnosine derivative within a promising cross-linked cyclodextrin spongey-like nanospheres on Physicochemical characterization and release behavior

Author(s)
Alia Badawi Department of Pharmaceutics, Faculty of Pharmacy, Cairo University,Cairo,Egypt
Magdy Mohammed Department of Pharmaceutics, Faculty of Pharmacy, Cairo University,Cairo,Egypt
Rawia Khalil Department of Pharmaceutical Technology, National Research Centre,Dokki, Giza,Egypt
Ruddy Ali Faculty of Pharmacy, 6 October University, Cairo, Egypt
Sally Abou Taleb Department of Pharmaceutical Technology, National Research Centre,Dokki, Giza,Egypt
Abstract
This study centered on the ability of the cross-linked nano-sponge system to load the drug and to improve its physicochemical and dissolution properties. A spectrophotometric method was used to determine the wavelength of maximum absorbance of the drug. The ultrasonic-assisted synthesis method was used for nano-sponge preparation. Solution-state interactions, encapsulation efficiency and production yield, and in-vitro release were also investigated. Nano-sponges were characterized by Transmission Electron-Microscopy (TEM), Scanning Electron-Microscopy (SEM), Fourier Transform-Infrared Spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), and X-Ray Diffractometry (X-RD) studies. The maximum absorption wavelength of N-acetyl-L-carnosine was found to be at 210 nm. Solutionstate interaction studies revealed a bathochromic shift. The production yield of nano-sponges ranged from 59.58% to 72.54%. In-vitro release study showed a sustained drug release for 228 hours. TEM images showed regular spherical shapes and sizes of nano-sponges. Their average particle size ranged from 28 nm to 79.2 nm. DSC data documented the drug-polymer interactions. FT-IR determined the presence of functional groups. X-RD showed the physicochemical characteristics of nano-sponges. Proving successful development of N-acetyl-L-carnosine polymeric nano-sponge system with a suitable drug delivery over an extended period beside a noticeable improvement in the physicochemical characterization.
Publication Details
Page(s) 283-290
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP1, Year: 2021

Request the full text from PASTIC

Keywords
ultrasonic technique release, Nano-sponge, N-acetyl-L-carnosine, hydroxy-propyl-ß-cyclodextrin
References
Abou Taleb S,Badawy Darwish A,Abood A,Mohamed AM .2020 .Investigation of a new horizon antifungal activity with enhancing the antimicrobial efficacy of ciprofloxacin and its binary mixture via their encapsulation in nanoassemblies: in vitro and in vivo evaluation. Drug Dev. Res., 81(3) : 347-388.
Ahmed RZ,Patil G,Zaheer Z G .2013 .Nanosponges-a completely new nano-horizon: Pharmaceutical applications and recent advances. Drug Dev, 39(9) : 1263-1272.
Allahyari S,Trotta F,Valizadeh H,Jelvehgari M,Zakeri-Milani P .2019 .Cyclodextrin-based nanosponges as promising carriers for active agents. Expert Opin, 16(5) : 467-479.
Ammar H,Ghorab M,Mostafa D,Makram T,Ali R .2013 .Host-guest system of etodolac in native and modified β-cyclodextrins: Preparation and physicochemical characterization. J. Incl. Phenom. Macrocycl. Chem, 77(1-4) : 121-134.
Ansari KA,Vavia PR,Trotta F,Cavalli R F .2011 .Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS Pharm. Sci. Tech, 12(1) : 279-286.
Babizhayev MA,Seguin M,Gueyne J,Evstigneeva R,Ageyeva E,Zheltukhina G .1994 .L-Carnosine (β- alanyl-L-histidine) and carcinine (β-alanylhistamine) act as natural antioxidants with hydroxyl-radicalscavenging and lipid-peroxidase activities. Biochem. J., 304(2) : 509-516.
Babizhayev MA,Yermakova VN,Sakina NL,Evstigneeva RP,Rozhkova EA,Zheltukhina GA. .1996 .Nα-Acetylcarnosine is a prodrug of Lcarnosine in ophthalmic application as antioxidant. Clin. Chim. Acta, 254(1) : 1-21.
Blanco J,Vila-jato JL,Otero F,Anguiano S F .1991 .Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins. Drug Dev, 17(7) : 943-957.
Branham ML,Singh P,Bisetty K,Sabela M,Govender T .2011 .Preparation, spectrochemical, and computational analysis of L-carnosine (2-[(3- aminopropanoyl) amino]-3-(1H-imidazol-5-yl) propanoic acid) and its ruthenium (II) coordination complexes in aqueous solution. Molecules, 16(12) : 10269-10291.
Cavalli R,Trotta F,Tumiatti W F .2006 .Cyclodextrinbased nanosponges for drug delivery. J. Incl. Phenom. Macrocycl. Chem, 56(1-2) : 209-213.
Challa R,Ahuja A,Ali J,Khar R .2005 .Cyclodextrins in drug delivery: An updated review. AAPS Pharm. Sci. Tech, 6(2) : E329-E357.
Connors KA. .1995 .Population characteristics of cyclodextrin complex stabilities in aqueous solution. J. Pharm. Sci., 84(7) : 843-848.
Esclusa-Diaz M,Gayo-Otero M,Perez-Marcos M,Torres-Labandeira J,J J .1996 .Preparation and evaluation of ketoconazole-β-cyclodextrin multicomponent complexes. Int. J. Pharm., 142(2) : 183-187.
Filipović-Grčić J,Voinovich D,Moneghini M,Bećirević- Laćan M,Magarotto L,Jalšenjak I .2000 .Chitosan microspheres with hydrocortisone and hydrocortisonehydroxypropyl-β-cyclodextrin inclusion complex. Eur. J. Pharm. Sci., 9(4) : 373-379.
Furniss BS .1989 .Vogel's textbook of practical organic chemistry. Pearson Education India., : .
Kacsó I,Borodi G,Farcas S,Hernanz A,Bratu I. .2010 .Host-guest system of Vitamin B10 in β- cyclodextrin: Characterization of the interaction in solution and in solid state. J. Incl. Phenom. Macrocycl. Chem, 68(1-2) : 175-182.
Loftsson T,Hreinsdottir D,Masson M D .2005 .Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm., 302(1-2) : 18-28.
Mura P,Adragna E,Rabasco A,Moyano J,PerezMartinez J,Arias M,Gines J .1999 .Effects of the host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin systems. Drug Dev, 25(3) : 279-287.
.2010 .Nanosponge drug delivery system more effective than direct injection. , : .
O'Dowd JJ,Robins DJ,Miller DJ DJ .1988 .Detection, characterisation, and quantification of carnosine and other histidyl derivatives in cardiac and skeletal muscle. Biochim. Biophys. Acta, 967(2) : 241-249.
Oppermann H,Heinrich M,Birkemeyer C,Meixensberger J,Gaunitz F J .2019 .The protoncoupled oligopeptide transporters PEPT2, PHT1 and PHT2 mediate the uptake of carnosine in glioblastoma cells. J. Amino Acids, 51(7) : 999-1008.
Penjuri SCB,Ravouru N,Damineni S,Bns S,Poreddy SR .2016 .Formulation and evaluation of lansoprazole loaded nanosponges. Turk J. Pharm. Sci., 13(3) : 304-310.
Rao M,Bajaj A,Khole I,Munjapara G,Trotta F G .2013 .In vitro and in vivo evaluation of bcyclodextrin-based nanosponges of telmisartan. J. Incl. Phenom. Macrocycl. Chem, 77(1-4) : 135-145.
Sinha V,Chadha R,Goel H R .2010 .Inter-molecular physiochemical characterization for etodolachydroxypropyl-β-cyclodextrin polymeric systems in solid and liquid state. Open Chemistry, 8(4) : 953-962.
Spulber M,Pinteala M,Fifere A,Moldoveanu C,Mangalagiu I,Harabagiu V,Simionescu BC .2008 .Water soluble complexes of methyl β- cyclodextrin and sulconazole nitrate. J. Incl. Phenom. Macrocycl. Chem, 62(1-2) : 135-142.
Swaminathan S,Pastero L,Serpe L,Trotta F,Vavia P,Aquilano D,Trotta M,Zara G,Cavalli R G .2010 .Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm., 74(2) : 193-201.
Swaminathan S,Vavia P,Trotta F,Torne S F .2007 .Formulation of betacyclodextrin based nanosponges of itraconazole. J. Incl. Phenom. Macrocycl. Chem, 57(1- 4) : 89-94.
Tejashri G,Amrita B,Darshana J .2013 .Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharm., 63(3) : 335-358.
Terekhova IV,Obukhova NA .2007 .Study on inclusion complex formation of m-aminobenzoic acid with native and substituted β-cyclodextrins. J. Sol. Chem, 36(9) : 1167-1176.
Tønnesen HH,Másson M,Loftsson T .2002 .Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int. J. Pharm., 244(1-2) : 127-135.
Torne S,Darandale S,Vavia P,Trotta F,Cavalli R. .2013 .Cyclodextrin-based nanosponges: Effective nanocarrier for Tamoxifen delivery. Pharm. Dev, 18(3) : 619-625.
Trotta F,Cavalli R,Tumiatti W,Zerbinati O,Roggero C,Vallero R C .2007 .Ultrasound-assisted synthesis of cyclodextrin-based nanosponges: Google Patents. , 1786841 : A1.
Trotta F,Zanetti M,Cavalli R M .2012 .Cyclodextrinbased nanosponges as drug carriers. Beilstein J. Org. Chem, 8(1) : 2091-2099.
0

Citations

0

Downloads

11

Views